Bell Rock Capital LLC Cara Therapeutics, Inc. Transaction History

Bell Rock Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$17.68 - $21.57 $21,216 - $25,884	-1,200 Closed	0 $0
Q2 2018 Nov 14, 2018	SELL	$11.6 - $19.27 $580 - $963	-50 Reduced 4.0%	1,200 $23,000
Q1 2018 Nov 14, 2018	BUY	$11.77 - $16.08 $2,942 - $4,019	250 Added 25.0%	1,250 $16,000
Q4 2017 Nov 13, 2018	BUY	$11.86 - $14.08 $4,151 - $4,928	350 Added 53.85%	1,000 $12,000
Q2 2017 Dec 06, 2018	BUY	N/A	650	650 $10,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.